Clinical Trial Update: To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC) [NA]

View source ↗

Summary

Completed clinical trial update studying protein changes in lung cells from Asian patients with advanced non-small cell lung cancer, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non Small Cell Lung Cancer | NA | Status: COMPLETED